sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  factor VIIa

Medicine

factor VIIa

SEVENFACT is indicated for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors.

Patient information

Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗

Drug facts

Used for
  • SEVENFACT is a recombinant human Factor VIIa protein for injection.
  • SEVENFACT can allow adolescents and adults with Hemophilia A or B with inhibitors to create clotting at the site of bleeding without needing Coagulation Factor VIII or IX replacement.
How to take it
  • Collect all materials needed for your prescribed dose
  • Follow the Instructions For Use guide to reconstitute the prescribed number of SEVENFACT vials
  • Infuse following your healthcare provider’s instructions, using infusion materials from your pharmacy
Do not take if
  • Are allergic to rabbits.
  • Have known allergies to SEVENFACT or any of its components.

What it is used for

SEVENFACT is a recombinant human Factor VIIa protein for injection. SEVENFACT can allow adolescents and adults with Hemophilia A or B with inhibitors to create clotting at the site of bleeding without needing Coagulation Factor VIII or IX replacement.

SEVENFACT, coagulation factor VIIa (recombinant)-jncw, is indicated for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with Hemophilia A or B with inhibitors.

Injecting medications requires special training. Do not attempt to self-infuse unless you have been taught how by your health care provider or hemophilia treatment center. Once trained, you will need additional infusion materials along with your SEVENFACT so that you can successfully treat your bleeding episodes at home. Be sure to collect all necessary infusion materials before starting the reconstitution process.

SEVENFACT comes in a sterile dry powdered dosage form that must be reconstituted with sterile Water for Injection.

It is not known if SEVENFACT is safe and effective in children under 12 years of age.

The most important thing to know

The most serious possible side effect of SEVENFACT is abnormal blood clotting involving blockage of blood vessels, which include stroke, blockage of the main blood vessel to the lung, and deep vein blood clots.

You should know the signs of abnormal clotting (thrombosis) described below and seek medical help immediately if they occur.

New onset of swelling and pain in the limbs or abdomen, new onset of chest pain, shortness of breath, loss of sensation or motor power, and altered consciousness or speech can all be signs of clot formation in places other than your site of bleeding. Seek immediate medical attention if you experience one or more of these symptoms.

SEVENFACT should be used as prescribed and directed by your healthcare provider.

How to take it

Treatment with SEVENFACT should be started by a healthcare provider who is experienced in the care of patients with Hemophilia A or B with inhibitors.

SEVENFACT is given as an injection into your vein.

You may infuse SEVENFACT at a hemophilia treatment center, at your healthcare provider’s office, or in your home. You should be trained on how to infuse by your healthcare provider or hemophilia treatment center. Many people with inhibitors learn to infuse by themselves or with the help of a family member.

Treating at first sign of a bleed is important for bleed management. Your healthcare provider will tell you how much SEVENFACT to use based on your weight and when to administer SEVENFACT.

To administer SEVENFACT:

  • Collect all materials needed for your prescribed dose
  • Follow the Instructions For Use guide to reconstitute the prescribed number of SEVENFACT vials
  • Infuse following your healthcare provider’s instructions, using infusion materials from your pharmacy

Contact your healthcare provider if you:

  • Miss a dose, or
  • Administer more than your prescribed dose, or
  • Think your bleed is not controlled within the expected time frame discussed with your healthcare provider.

Side effects, and when to stop

The most common adverse reactions reported in clinical trials for SEVENFACT were headache, dizziness, infusion-site discomfort, infusion-site hematoma, infusion-related reaction and fever.

A serious allergic reaction to SEVENFACT may occur. If you experience the severe symptoms of an allergic reaction after infusing SEVENFACT, seek immediate medical attention. Severe symptoms occur when your immune system reacts very strongly to foreign proteins or drugs.

  • Hives, itching, rash, difficulty breathing with cough or wheezing, swelling around the mouth and throat, tightness of the chest, dizziness or fainting, and low blood pressure are all symptoms of a severe allergic reaction (anaphylaxis). Call 911 should you experience one or more of these symptoms.

These are not all the possible side effects of SEVENFACT. For more information, ask your healthcare provider or pharmacist.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Who should not take it

You should not use SEVENFACT if you:

  • Are allergic to rabbits.
  • Have known allergies to SEVENFACT or any of its components.

Tell your doctor prior to infusing SEVENFACT if you have begun treatment of a bleeding episode with another bypassing agent such as activated prothrombin complex concentrate (FEIBA ® ).

What to say before you start

Tell your healthcare provider if you:

  • Are pregnant, planning to become pregnant or nursing, as SEVENFACT has not been studied in patients with Hemophilia A or B with inhibitors who are pregnant or nursing.
  • Had prior blood clots, heart disease, heart failure, abnormal heart rhythms, prior pulmonary clots or heart surgery.
  • Have or have had any other medical conditions.

You and your doctor can then decide whether SEVENFACT is the right treatment for you, as well as the proper timing and doses you will need for SEVENFACT to control your bleeding episodes at home.

What to avoid

  • Avoid activity that can create more bleeding once you have completed your SEVENFACT infusion
  • Avoid mixing SEVENFACT with other medications
  • Avoid infusing SEVENFACT and other factor-containing therapies [such as activated prothrombin complex concentrate (aPCC) or other recombinant Factor VIIa products] at the same time. This increases your risk of having a disabling blood clot.

Storing it

  • SEVENFACT should be stored in its product packaging to protect from light.
  • Prior to reconstitution, the SEVENFACT kit should be stored at room temperature but can be stored between 36°F to 86°F (2°C to 30°C).
  • After reconstitution, SEVENFACT should be stored at room temperature but can be stored between 36°F to 86°F (2°C to 30°C), for up to 4 hours.
  • SEVENFACT should not be frozen.

General information about the safe and effective use of SEVENFACT

SEVENFACT is sometimes prescribed for purposes other than those listed here.

This leaflet summarizes the most important information about SEVENFACT.

Do not use SEVENFACT for a condition for which it was not prescribed. Do not give SEVENFACT to other people even if they have the same symptoms you have. It may harm them.

You can ask your pharmacist or healthcare provider for information about SEVENFACT that is written for health professionals.

For more information, go to www.SEVENFACT.com or call 855.718.HEMA (4362).

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. factor VIIa; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/factor-viia

APA 7th

sofidex. (2026, August 2). factor VIIa. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/factor-viia

AMA 11th

factor VIIa. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/factor-viia

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.